Total Holdings
55
Portfolio diversification across 55 positions
PBPH
(NASDAQ)Portfolio Building Block World Pharma and Biotech Index ETF
$27.33-- (--)
Loading... - Market loading
PBPH ETF Holdings: Portfolio Building Block World Pharma and Biotech Index ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$36.36M
Total fund assets
Expense Ratio
0.13%
Annual management fee
Fund Issuer
Portfolio Building Block
NASDAQ
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 50 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Eli Lilly and Company | Stock | 15.57% |
| 2 |  | Johnson & Johnson | Stock | 9.39% |
| 3 |  | AbbVie Inc | Stock | 6.92% |
| 4 | S SWX:ROG | Roche Holding AG | Stock | 5.27% |
| 5 | S SWX:NOVN | Novartis AG | Stock | 5.07% |
| 6 |  | Merck & Co., Inc. | Stock | 5.05% |
| 7 | L LSE:AZN | AstraZeneca PLC | Stock | 4.65% |
| 8 |  | Amgen Inc. | Stock | 4.59% |
| 9 | L LON:AZN | AstraZeneca PLC | Stock | 4.59% |
| 10 |  | Gilead Sciences, Inc. | Stock | 4.25% |
| 11 | L LSE:0QIU | Novo Nordisk A/S Class B | Stock | 3.97% |
| 12 |  | Pfizer Inc. | Stock | 3.44% |
| 13 | C CPH:NOVO.B | Novo Nordisk A/S | Stock | 3.25% |
| 14 |  | Bristol-Myers Squibb Company | Stock | 2.78% |
| 15 |  | Vertex Pharmaceuticals Incorporated | Stock | 2.78% |
| 16 | L LON:GSK | GSK plc | Stock | 2.67% |
| 17 | E EPA:SAN | Sanofi | Stock | 2.61% |
| 18 | L LSE:GSK | GlaxoSmithKline plc | Stock | 2.29% |
| 19 |  | Regeneron Pharmaceuticals, Inc | Stock | 1.85% |
| 20 | A ASX:CSL | CSL Limited | Stock | 1.39% |
| 21 | T TYO:4502 | Takeda Pharmaceutical Company Limited | Stock | 1.34% |
| 22 |  | Zoetis Inc | Stock | 1.33% |
| 23 | E EBR:ARGX | argenx SE | Stock | 1.26% |
| 24 |  | Alnylam Pharmaceuticals, Inc | Stock | 1.18% |
| 25 | E ETR:BAYN | Bayer Aktiengesellschaft | Stock | 1.18% |
| 26 | T TSE:4502 | Takeda Pharmaceutical Co. Ltd. | Stock | 1.17% |
| 27 | L LON:HLN | Haleon plc | Stock | 1.08% |
| 28 | L LSE:HLN | Haleon PLC | Stock | 1.04% |
| 29 |  | Insmed Incorporated | Stock | 0.91% |
| 30 | T TLV:TEVA | Teva Pharmaceutical Industries Limited | Stock | 0.88% |
| 31 | E EBR:UCB | UCB SA | Stock | 0.85% |
| 32 | T TSE:4568 | Daiichi Sankyo Co. Ltd. | Stock | 0.84% |
| 33 | T TA:TEVA | Teva Pharmaceutical Industries Ltd | Stock | 0.82% |
| 34 | T TSE:4519 | Chugai Pharmaceutical Co. Ltd. | Stock | 0.79% |
| 35 |  | Natera, Inc | Stock | 0.74% |
| 36 | S SWX:SDZ | Sandoz Group AG | Stock | 0.73% |
| 37 | S SWX:GALD | Galderma Group N | Stock | 0.65% |
| 38 |  | Biogen Inc | Stock | 0.61% |
| 39 | T TSE:4578 | Otsuka Holdings Ltd | Stock | 0.57% |
| 40 | T TSE:4503 | Astellas Pharma Inc. | Stock | 0.57% |
| 41 |  | United Therapeutics Corporation | Stock | 0.51% |
| 42 |  | Incyte Corporation | Stock | 0.47% |
| 43 |  | Exact Sciences Corporation | Stock | 0.44% |
| 44 |  | Neurocrine Biosciences, Inc | Stock | 0.33% |
| 45 |  | Viatris Inc | Stock | 0.33% |
| 46 |  | Royalty Pharma plc | Stock | 0.32% |
| 47 |  | Revolution Medicines, Inc | Stock | 0.32% |
| 48 |  | Ionis Pharmaceuticals, Inc | Stock | 0.31% |
| 49 | T TSE:4507 | Shionogi & Co. Ltd. | Stock | 0.30% |
| 50 |  | BridgeBio Pharma, Inc | Stock | 0.29% |